Aortic aneurysms and miscellaneous disorders Flashcards
thoracic aortic aneurysm
> 4cm in ascending
>3 cm in descending
causes of aortic aneurysm
atherosclerosis, connective issue disorder, bicuspid aortic valve, vasculitis (Takayasu, giant cell, akylosing spondylitis, relapsing polychondritis), cystic medial necrosis, infectious aortitis
annuloaortic ectasia
dilated sinuses of Valsava and ascending aorta with effacement of sinotubular junction; tulip bulb shaped aorta
treatment for ascending thoracic aortic aneurysm
> 5.5 cm in diameter in ascending
6 cm in descending
lower threshold >4.5 cm with connective tissue disorders or bicuspid aortic valve or if annual growth rate >1 cm/yr
draped aorta sign
drooping posterior aorta against spine
sign of impending rupture
complications of TAA treatment
rupture, dissection, infection, endoleak, paraplegia (artery of Adamkiewicz occlusion)
abdominal aortic aneurysm
> 3cm
guidelines to monitor aneurysm
<4 cm: f/u in 6 months; anual surveillance
4-4.6: f/u 6 months, if no change 6 mo surveillance
5-5.5 cm: consider surgery
> 5.5 cm: surgery
endoleak
persistent flow into excluded aneurysm sac after endovascular treatment with stent graft
Type I endoleak
inadequate graft seal; IA proximal leak, IB distal leak
type II endoleak
persistent collateral flow to excluded leak
usually lumbar arteries or IMA
type III endoleak
device failure causing leakage
type IV/V endoleak
no endoleak seen on imaging; diagnosis of exclusion
IV: porous graft; transient, usually resolves; not seen with modern grafts
V: endotension; expansion of aneurysm without any other endoleak present
aortitis
Takayasu, giant cell arteritis, ankylosing spondylitis, polyarteritis nodosa, rheumatoid arthritis, immune complex disease
may result in mycotic aneurysm
imaging of aortitis acute/chronic
acute: circumferential mural thickening/enhancement; aneurysm/dissection/IMH
wall thickness >2mm and enhancement on MRI
chronic: long segmental stenoses/aneurysm